| |
|
|
|
Citius Pharmaceuticals Inc  
|
|
2.09 0 (0%) |
10-18 16:00 |
|
Open: |
2.08 |
Pre close: |
2.09 |
Target:
|
2.49
|
|
High: |
2.16 |
Low: |
2.07 |
Resistance:
|
2.13
2.25
|
|
Volume: |
1,878,615 |
Market Cap: |
283M |
Support:
|
1.94
1.61
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
2.09
 |
MACD |
MACD(12,26):
|
0.01 |
|
MA(20): |
2.06 |
Signal(12,26,9): |
0.00 |
|
MA(100): |
2.27  |
Stochastic Oscillator |
%K(14,3):
|
63.16 |
|
MA(250): |
1.81 |
%D(3): |
58.27 |
|
Average Volume(K) |
3-Month: |
262801
|
52-Week |
High:
|
4.56 |
|
10-Days: |
199751 |
Low: |
0.87 |
|
RSI |
RSI(14):
|
51.93 |
Change(%): |
80.2 |
|
Financials, Statistics and Valuation |
|
EPS |
-0.345 |
Return on Equity (ttm) |
-26.8 |
Shares Out. (M) |
135.47 |
|
EPS Est. Current Year |
0.000 |
Return on Assets (ttm) |
-15.2 |
Shares Float (M) |
133.67 |
|
EPS Est. Next Year |
0.000 |
PEG Ratio |
0.00 |
% Held by Insiders |
8.43 |
|
EPS Est. Next Quarter |
0.000 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
22.17 |
|
Forward EPS |
-1.170 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
13700 |
|
Book Value (p.s.) |
0.930 |
EBITDA (p.s.) |
-0.166 |
P/E |
-6.06 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
2.25 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-22.02 |
P/S |
0.00 |
|
Operating Margin |
0.00 |
Levered Free Cash Flow
(M) |
-13.73 |
P/CF |
-12.86 |
|
|
|
|
|
|
